AYRTN - Ayrton Drugs Manufacturing Co.
Ayrton Drugs is a pharmaceutical company that manufactures high quality medicines at affordable prices. It also deals with exportation and importation of drugs. The company was incorporated on 24th September, 1965 and was then issued with a certificate to commence Ayrton Drugs Manufacturing on 21st October, 1965. The company began in a small plant in Kokomlemle with a few tablet making machines and 10 employees. It moved to its current location on the Abeka Road, Tesano in 1969. It currently employs about 348 people.
|Last Trading Results||Growth & Valuation|
|Opening Price:||--||Earnings Per Share:||-0.0058|
|Day's Low Price:||--||Price/Earning Ratio:||-13.74|
|Day's High Price:||--||Dividend Per Share:||0.00|
|Traded Volume:||0||Dividend Yield:||0%|
|Number of Deals:||0||Shares Outstanding:||215m|
AYRTN Stock Market Performance
The current share price of Ayrton Drugs Manufacturing Co. (AYRTN) is GHS 0.08. The AYRTN stock closed its last trading day (Tuesday, December 24, 2019) at 0.08 GHS per share on the Ghana Stock Exchange. The table below details the last 10 trading days of activity of Ayrton Drugs Manufacturing Co. on the Ghana Stock Exchange.
NOTE: Shares of Ayrton Drugs Manufacturing Co. (AYRTN) have been delisted from the Ghana Stock Exchange since close of trading on Tuesday, January 14, 2020.
Profile of Ayrton Drugs Manufacturing Company Ltd.
Ayrton Drugs Manufacturing Company Ltd. operates in the Health Care sector. Unfortunately, we do not have information on the company's board of directors and/or key executives at this time.
|Factsheet of Ayrton Drugs Manufacturing Company Ltd.|
P. O. Box 2149, Accra
AYRTN Industrial Market Competitors
Ayrton Drugs Manufacturing Company Ltd., issuers of the AYRTN stock on the Ghana Stock Exchange, have two market competitors who are also engaged in the Health Care sector. The table below gives you an overview of their market standing.
|Code||Name||Mkt. Cap.||L. Price||YearTD|
|DASPHARMA||Dannex Ayrton Starwin Plc||33.91m||0.40||+0.00%|
|IIL||Intravenous Infusions Limited||10.35m||0.04||-20.0%|